P Hantraye

Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

D Comar, J. Baron, Y. Samson, 1985, European journal of pharmacology.

Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-Dopa

M. Grégoire, F. Condé, F. Dollé, 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Brain GABA editing without macromolecule contamination

G. Bloch, P. Hantraye, P. Henry, 2001, Magnetic resonance in medicine.

Novel therapies in the search for a cure for Huntington's disease.

M. Beal, P. Hantraye, M F Beal, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.

P Aebischer, P Brugières, J. Bloch, 2004, Human gene therapy.

Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism

G L Brownell, R D Spealman, G. Brownell, 1992, Neuroreport.

Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography.

D Comar, D. Comar, P. Hantraye, 1984, The International journal of applied radiation and isotopes.